MedTrace Pharma A/S: Financial statements 2016
CVR: 36497661
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
MedTrace Pharma A/S (CVR 36497661) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 1,519,441 and a net result of DKK 1,157,243 compared with DKK -245,485,000 the year before. Equity in the 2016 report amounted to DKK 4,157,111. The solvency ratio was 39.3%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 1,519,441
- Profit/Loss
- DKK 1,157,243
- Equity
- DKK 4,157,111
- Total Assets
- DKK 10,579,933
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 1.5 mio. | 1.2 mio. | 4.2 mio. | 4 |
| 2015 | - | -232.4 mio. | -245.5 mio. | 2.8 mia. | - |
Official annual report
Find more companies like MedTrace Pharma A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
As of August 4, 2016, Lenna Maria Boe Broberg has joined the board of directors of MedTrace Pharma A/S.
MedTrace Pharma A/S has published its annual report for 2015. Gross profit came to DKK -232,409,000, and the net result was DKK -245,485,000.
About MedTrace Pharma A/S
MedTrace Pharma A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2015. The company is registered under the industry Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver til events. The company was previously named MedTrace A/S and Medtrace ApS. The management consists of Peter Juul Kristensen and Lykke Jul Rømer. The board consists of Erik Anders Strömqvist (chair), Cesare Orlandi, Charlotte Vindfeldt and Claus Henrik Berner Møller. The company's owners include Arbejdsmarkedets Tillægspension, MedTravest IV ApS and Swisscanto Private Equity I KmGK. The company has 32 employees (2026). In 2025, the company reported revenue of DKK 1,759,371 and a net result of DKK -35,131,112 compared with DKK -15,355,876 the year before. Equity in the 2025 report amounted to DKK 302,613,643.